R3 Delta Ceramic Acetabular System PAS U.S.

CompletedOBSERVATIONAL
Enrollment

189

Participants

Timeline

Start Date

February 7, 2018

Primary Completion Date

May 31, 2023

Study Completion Date

May 31, 2023

Conditions
Degenerative Joint Disease
Interventions
DEVICE

R3 Biolox Delta Ceramic Acetabular System

All study related procedures with the R3 delta Ceramic Acetabular System must be performed according to the recommended surgical technique described in the labeling and in the instructions for use (IFU).

Trial Locations (8)

19104

University of Pennsylvania, Department of Orthopaedic Surgery, Philadelphia

21215

Rubin Institute for Advanced Orthopedics, Sinai Hospital, Baltimore

21401

Luminis Health, Annapolis

30084

Emory University, Tucker

33637

Foundation for Orthopaedic Research and Education, Tampa

77043

INOV8 Healthcare, Houston

78750

St. David's Center for Hip and Knee Replacement, Austin

89503

Reno Orthopaedic Clinic Foundation, Reno

All Listed Sponsors
lead

Smith & Nephew, Inc.

INDUSTRY

NCT03056534 - R3 Delta Ceramic Acetabular System PAS U.S. | Biotech Hunter | Biotech Hunter